The US Safety Lancet Market growth continues to accelerate as regulatory frameworks evolve to address emerging safety concerns and technological capabilities in capillary blood collection devices. The FDA has intensified scrutiny of safety lancet performance claims, requiring robust clinical evidence that safety features activate consistently across diverse user populations and clinical...